Because CD8+ T lymphocytes could efficiently destroy tumour cells and CD4+ lymphocytes aided the immune system in its fight against microorganisms, the amount of CD8+ and CD4+ T cells was greater in the cGAMP-treatment group (Figure 7(A,B)). The gene discussed is CD4; the disease is neoplasm.